159 related articles for article (PubMed ID: 25277819)
1. Risk of contralateral second primary breast cancer according to hormone receptor status in Germany.
Rusner C; Wolf K; Bandemer-Greulich U; Engel J; Stegmaier C; Holleczek B; Schubert-Fritschle G; Tillack A; Stang A
Breast Cancer Res; 2014 Oct; 16(5):452. PubMed ID: 25277819
[TBL] [Abstract][Full Text] [Related]
2. Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer.
Bessonova L; Taylor TH; Mehta RS; Zell JA; Anton-Culver H
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):389-96. PubMed ID: 21217087
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.
Saltzman BS; Malone KE; McDougall JA; Daling JR; Li CI
Breast Cancer Res Treat; 2012 Oct; 135(3):849-55. PubMed ID: 22903686
[TBL] [Abstract][Full Text] [Related]
4. Second primary breast cancer occurrence according to hormone receptor status.
Kurian AW; McClure LA; John EM; Horn-Ross PL; Ford JM; Clarke CA
J Natl Cancer Inst; 2009 Aug; 101(15):1058-65. PubMed ID: 19590058
[TBL] [Abstract][Full Text] [Related]
5. Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries.
Mezencev R; Švajdler M
Breast Cancer; 2017 May; 24(3):400-410. PubMed ID: 27502779
[TBL] [Abstract][Full Text] [Related]
6. Second cancers following in situ carcinoma of the breast.
Franceschi S; Levi F; La Vecchia C; Randimbison L; Te VC
Int J Cancer; 1998 Jul; 77(3):392-5. PubMed ID: 9663601
[TBL] [Abstract][Full Text] [Related]
7. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
[TBL] [Abstract][Full Text] [Related]
8. Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992-2016.
Ramin C; Withrow DR; Davis Lynn BC; Gierach GL; Berrington de González A
Breast Cancer Res; 2021 Feb; 23(1):24. PubMed ID: 33596988
[TBL] [Abstract][Full Text] [Related]
9. Incidence, mortality and receptor status of breast cancer in African Caribbean women: Data from the cancer registry of Guadeloupe.
Deloumeaux J; Gaumond S; Bhakkan B; Manip M'Ebobisse N; Lafrance W; Lancelot P; Vacque D; Negesse Y; Diedhiou A; Kadhel P
Cancer Epidemiol; 2017 Apr; 47():42-47. PubMed ID: 28119121
[TBL] [Abstract][Full Text] [Related]
10. Association between common risk factors and molecular subtypes in breast cancer patients.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738
[TBL] [Abstract][Full Text] [Related]
11. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
13. Progestagens use before menopause and breast cancer risk according to histology and hormone receptors.
Fabre A; Fournier A; Mesrine S; Gompel A; Desreux J; Berrino F; Boutron-Ruault MC; Romieu I; Clavel-Chapelon F
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2723-8. PubMed ID: 18843015
[TBL] [Abstract][Full Text] [Related]
14. Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status.
Mao K; Yang Y; Wu W; Liang S; Deng H; Liu J
PLoS One; 2017; 12(5):e0176417. PubMed ID: 28467490
[TBL] [Abstract][Full Text] [Related]
15. Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study.
Williams LA; Nichols HB; Hoadley KA; Tse CK; Geradts J; Bell ME; Perou CM; Love MI; Olshan AF; Troester MA
Cancer Causes Control; 2018 Jan; 29(1):25-32. PubMed ID: 29124544
[TBL] [Abstract][Full Text] [Related]
16. Associations of race and ethnicity with risk of developing invasive breast cancer after lobular carcinoma in situ.
Dania V; Liu Y; Ademuyiwa F; Weber JD; Colditz GA
Breast Cancer Res; 2019 Nov; 21(1):120. PubMed ID: 31727116
[TBL] [Abstract][Full Text] [Related]
17. Mammographic breast density is associated with the development of contralateral breast cancer.
Raghavendra A; Sinha AK; Le-Petross HT; Garg N; Hsu L; Patangan M; Bevers TB; Shen Y; Banu A; Tripathy D; Bedrosian I; Barcenas CH
Cancer; 2017 Jun; 123(11):1935-1940. PubMed ID: 28135395
[TBL] [Abstract][Full Text] [Related]
18. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
[TBL] [Abstract][Full Text] [Related]
19. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
Li CI; Chlebowski RT; Freiberg M; Johnson KC; Kuller L; Lane D; Lessin L; O'Sullivan MJ; Wactawski-Wende J; Yasmeen S; Prentice R
J Natl Cancer Inst; 2010 Sep; 102(18):1422-31. PubMed ID: 20733117
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study.
Nyante SJ; Dallal CM; Gierach GL; Park Y; Hollenbeck AR; Brinton LA
Am J Epidemiol; 2013 Aug; 178(3):359-71. PubMed ID: 23899816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
